发明名称 CARDIAC GLYCOSIDE COMPOSITION
摘要 The solubility of pharmaceuticals for application in gelatin capsules is increased by dissolving them in monoglycerides- and opt. diglycerides of 8-12C fatty acids. The process increases the reabsorption from the gastrointestinal tract and gives greater dosage accuracy. In an example, 1 ml. of fatty acid glyceride mixt. was used to dissolve (a) 5 mg. g-strophanthin; (b) 100 mg. benzanone; (c) 5 mg. digoxin.
申请公布号 AU2692777(A) 申请公布日期 1979.01.18
申请号 AU19770026927 申请日期 1977.07.11
申请人 KALI-CHEMIE PHARMA GMBH 发明人 THEODOR ECKERT;FRITZ H. KEMPER;MARTIN WISCHNIEWSKI;REINHARD HEMPEL
分类号 A61K9/107;A61K9/02;A61K9/48;A61K47/14 主分类号 A61K9/107
代理机构 代理人
主权项
地址